Hakim-Moulay Dehbi

Years Active: 2020-2024
Publications (10 Years): 5

Imperial College London (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Imperial College London Oct 01 2013 - Sep 26 2016

United Kingdom

PHD

Publications

Codruta Chiuzan, Hakim-Moulay Dehbi
The 3 + 3 design in dose-finding studies with small sample sizes: Pitfalls and possible remedies. Clinical trials (London, England) 21 (3) (2024)
Codruta Chiuzan, Hakim-Moulay Dehbi
The 3 + 3 design in dose-finding studies with small sample sizes: Pitfalls and possible remedies. Clinical trials (London, England) (2024)
David M Lowe, Li-An K Brown, Kashfia Chowdhury, Stephanie Davey, Philip Yee, Felicia Ikeji, Amalia Ndoutoumou, Divya Shah, Alexander Lennon, Abhulya Rai, Akosua A Agyeman, Anna Checkley, Nicola Longley, Hakim-Moulay Dehbi, Nick Freemantle, Juanita Pang, Joseph F Standing, null null
Favipiravir, lopinavir-ritonavir, or combination therapy (FLARE): A randomised, double-blind, 2 × 2 factorial placebo-controlled trial of early antiviral therapy in COVID-19. PLoS medicine 19 (10) (2022)
Hakim-Moulay Dehbi, Andrew Embleton-Thirsk, Zachary Ryan McCaw
Sample size calculation for randomized selection trials with a time-to-event endpoint and a margin of practical equivalence. Statistics in medicine 41 (20) (2022)
Hakim-Moulay Dehbi, David M Lowe, John O'Quigley
Early phase dose-finding trials in virology. Statistics in medicine 40 (2) (2020)

Hakim-Moulay Dehbi.css-eqlu8i{font-size:small;padding-left:4px;}